PL4401743T3 - Kompozycja zawierająca hialuronian sodu i aminokwasy do stosowania w dziedzinie ortopedii - Google Patents
Kompozycja zawierająca hialuronian sodu i aminokwasy do stosowania w dziedzinie ortopediiInfo
- Publication number
- PL4401743T3 PL4401743T3 PL22789675.0T PL22789675T PL4401743T3 PL 4401743 T3 PL4401743 T3 PL 4401743T3 PL 22789675 T PL22789675 T PL 22789675T PL 4401743 T3 PL4401743 T3 PL 4401743T3
- Authority
- PL
- Poland
- Prior art keywords
- orthopedics
- amino acids
- field
- composition containing
- sodium hyaluronate
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physical Education & Sports Medicine (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT102021000023894A IT202100023894A1 (it) | 2021-09-16 | 2021-09-16 | Composizione per utilizzo in campo ortopedico |
| PCT/IB2022/058720 WO2023042120A1 (en) | 2021-09-16 | 2022-09-15 | Composition comprising sodium hyaluronate and am inoacids for use in the orthopedic filed |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL4401743T3 true PL4401743T3 (pl) | 2025-12-15 |
Family
ID=78771031
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL22789675.0T PL4401743T3 (pl) | 2021-09-16 | 2022-09-15 | Kompozycja zawierająca hialuronian sodu i aminokwasy do stosowania w dziedzinie ortopedii |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240366653A1 (pl) |
| EP (1) | EP4401743B1 (pl) |
| KR (1) | KR20240063914A (pl) |
| CN (1) | CN117957004A (pl) |
| AU (1) | AU2022345524A1 (pl) |
| ES (1) | ES3052874T3 (pl) |
| HR (1) | HRP20251328T1 (pl) |
| IT (1) | IT202100023894A1 (pl) |
| PL (1) | PL4401743T3 (pl) |
| RS (1) | RS67349B1 (pl) |
| WO (1) | WO2023042120A1 (pl) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LU505892B1 (fr) * | 2023-12-21 | 2025-06-24 | Lumatrix | Formule pharmaceutique de cicatrisation et de régénération de la peau et son utilisation |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITMI20052515A1 (it) * | 2005-12-29 | 2007-06-30 | Abiogen Pharma Spa | Formulazione farmaceutica per il trattamento della osteoartrite |
| CA2910325A1 (en) * | 2013-04-25 | 2014-10-30 | Aluron Biopharma Inc. | Crosslinked hyaluronic acid compositions |
-
2021
- 2021-09-16 IT IT102021000023894A patent/IT202100023894A1/it unknown
-
2022
- 2022-09-15 KR KR1020247009798A patent/KR20240063914A/ko active Pending
- 2022-09-15 CN CN202280062464.8A patent/CN117957004A/zh active Pending
- 2022-09-15 AU AU2022345524A patent/AU2022345524A1/en active Pending
- 2022-09-15 US US18/691,052 patent/US20240366653A1/en active Pending
- 2022-09-15 ES ES22789675T patent/ES3052874T3/es active Active
- 2022-09-15 EP EP22789675.0A patent/EP4401743B1/en active Active
- 2022-09-15 HR HRP20251328TT patent/HRP20251328T1/hr unknown
- 2022-09-15 PL PL22789675.0T patent/PL4401743T3/pl unknown
- 2022-09-15 WO PCT/IB2022/058720 patent/WO2023042120A1/en not_active Ceased
- 2022-09-15 RS RS20251080A patent/RS67349B1/sr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2022345524A1 (en) | 2024-02-15 |
| HRP20251328T1 (hr) | 2025-12-19 |
| IT202100023894A1 (it) | 2023-03-16 |
| EP4401743B1 (en) | 2025-09-03 |
| CN117957004A (zh) | 2024-04-30 |
| RS67349B1 (sr) | 2025-11-28 |
| EP4401743C0 (en) | 2025-09-03 |
| ES3052874T3 (en) | 2026-01-15 |
| WO2023042120A1 (en) | 2023-03-23 |
| KR20240063914A (ko) | 2024-05-10 |
| US20240366653A1 (en) | 2024-11-07 |
| EP4401743A1 (en) | 2024-07-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX376139B (es) | Formulaciones y metodos de tratamiento con queratina. | |
| EP4212524A4 (en) | Cd73 inhibitor and application thereof in medicine | |
| ITRM20030210A1 (it) | Protesi da impiegarsi nella terapia chirurgica del prolasso | |
| BR112015007746A2 (pt) | formulação aquosa estéril injetável, kit contendo a formulação aquosa estéril injetável e processo de fabricação de uma formulação aquosa estéril injetável | |
| ZA202007834B (en) | Compositions comprising amino acids for use in the prevention and treatment of liver diseases | |
| NO20051539L (no) | N-biarylmetylaminosykloalkankarboksamidderivater | |
| BR112013004436A2 (pt) | composições e usos de materiais com atividade microbicida alta e toxicidade baixa | |
| BR112015026247A8 (pt) | composto em combinação com um análogo de citidina, composição farmacêutica que os compreende, uso dos mesmos e kit | |
| IL308041A (en) | Collagen compositions and methods of using them | |
| MA48464A (fr) | Dipeptides n-acétylés et non acétylés contenant de l'arginine destinés à réduire la viscosité de compositions visqueuses de polypeptides thérapeutiques | |
| PL4132895T3 (pl) | Kompozycja częściowo protonowanych alkanoloamin i zastosowanie w młynie | |
| ZA202207728B (en) | Compositions comprising amino acids for use in the prevention and treatment of chemotherapy side effects | |
| IT201700085412A1 (it) | Composizione per uso nella prevenzione e nel trattamento di patologie dell'apparato cardiovascolare | |
| PL4401743T3 (pl) | Kompozycja zawierająca hialuronian sodu i aminokwasy do stosowania w dziedzinie ortopedii | |
| PH12019501999A1 (en) | Pyrazole derivatives as bromodomain inhibitors | |
| PL3478310T3 (pl) | Kompozycje przydatne w zapobieganiu i/lub leczeniu zapalenia i bólu stawów i kości oraz uszkodzenia chrząstki | |
| BRPI0707420A8 (pt) | composições contendo peptídeos com aminoácidos e métodos não naturais do uso | |
| IL290846A (en) | Liquid compositions comprising a levodopa amino acid conjugate and uses thereof | |
| EP4262637C0 (en) | IMPROVEMENTS MADE IN OR RELATING TO SURGICAL METHODS AND SYSTEMS | |
| DE60307665D1 (de) | Haarbehandlungszusammensetzungen mit xanthin und alpha-hydroxysäure | |
| BR112018003455A2 (pt) | composição ou composição farmacêutica e uso da composição | |
| MX2022007219A (es) | Compuestos y su uso para el tratamiento contra la deficiencia de ¿1- antitripsina. | |
| EP3819362A4 (en) | GEL-SHAPED DETERGENT COMPOSITION AND DETERGENT PRODUCT | |
| PL3813882T3 (pl) | Kombinacja farmaceutyczna zawierająca biguanid i inhibitor acetylocholinoesterazy do stosowania w chorobach związanych z wiekiem i/lub chorobach zwyrodnieniowych | |
| DE602006020155D1 (de) | Pharmazeutische wundheilungs-zusammensetzungen in ren und natriumhyaluronat |